As previously reported, BofA upgraded Pitney Bowes (PBI) to Neutral from Underperform with a price target of $16.50, up from $9.50, following better-than-expected Q1 results. Given its view that Pitney Bowes is “beginning to turn a corner” on stabilizing revenue declines, coupled with meaningful cost take-out since 2024 and robust share buybacks, the firm is more confident on operating earnings growth and capital return, but sees shares as discounting much of a potential turnaround with the stock up about 50% year-to-date, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PBI:
- Pitney Bowes price target raised to $15.20 from $13.70 at Goldman Sachs
- Pitney Bowes price target raised to $15 from $11 at Truist
- Pitney Bowes Earnings Call Signals Cautious Turnaround
- Pitney achieves Provisional Authorization for Impact Level 4 for SendPro 360
- Pitney Bowes price target raised to $13.70 from $12 at Goldman Sachs
